| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3403054 | Enfermedades Infecciosas y Microbiología Clínica | 2006 | 12 Pages |
Abstract
Chronic hepatitis due to hepatitis C virus (HCV) infection is now one of the leading causes of morbidity and mortality among HIV-infected individuals. Coinfected patients present an accelerated course toward cirrhosis and an enhanced risk of liver toxicity associated with the use of antiretroviral agents. Treatment of chronic hepatitis C in HIV+ patients is less efficacious than in HCV-monoinfected individuals and requires particular expertise.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Andrés Ruiz-Sancho, Vicente Soriano,